Brimoct 2,0 Mg/Ml Ophthalmic 2,0mg/ml Ophthalmic Solution
PDF Leaflet Revision Date: 07 December 2020
Clinical Summary
Quick overview from the medicine insert
Indication
Lowering intraocular pressure in open-angle glaucoma or ocular hypertension.
Dosage (summary)
One drop in affected eye(s) twice daily, 12 hours apart.
Onset of Action / Duration
Onset: 2 hours, Duration: Not specified.
Special Populations
- Children under 2 years
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; unknown if excreted in breast milk.
Key Drug Interactions
- CNS depressants
- Beta blockers
- Antihypertensives
- Tricyclic antidepressants
Contraindications
- Hypersensitivity to brimonidine or benzalkonium chloride
- MAO inhibitor therapy
Common side effects
- Conjunctival hyperaemia
- Eye pruritus
- Headache
- Dizziness
- Fatigue
Counselling Points
- Wait 15 mins before inserting soft contact lenses
- May cause blurred vision
- Avoid driving until sure of vision
Serious warnings
- Caution in severe cardiovascular disease
- Potential for dry eyes
- Regular ophthalmological examination required
Important Disclaimer
The Brimoct 2,0 Mg/Ml Ophthalmic 2,0mg/ml Ophthalmic Solution professional information leaflet below is the property of Gen-Eye and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
